Patents
Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008)
09/2007
09/07/2007WO2007067698A3 Isolation of ansamitocins
09/07/2007WO2005051313A3 Methods and reagents for treating, preventing and diagnosing bunyavirus infection
09/07/2007CA2614639A1 Pharmaceutical composition for treatment of blood clotting disorder
09/06/2007US20070208170 Intermediate and process for preparing of beta- anomer enriched 21-deoxy,21,21-difluoro-d-ribofuranosyl nucleosides
09/06/2007US20070208169 Labeled-imidazole-Polyethylene glycol compounds; nonpurine- and nonpyrimidine-based nucleotides; nucleotide sequence detectors
09/06/2007US20070207978 Stimulate mammalian coronary vasodilatation; imaging the heart; antiinflammatory; adjunctive therapy with angioplasty; platelet aggregation inhibitor; inhibitor of platelet and neutrophil activation;
09/06/2007US20070207973 1,3,5-Triazines for Treatment of Viral Diseases
09/06/2007US20070207943 Interleukins-21 and 22
09/05/2007EP1829885A1 Modified 5'- phosphonate azidothymidine-potential anti-viral preparations
09/05/2007EP1828217A2 Polymerase-independent analysis of the sequence of polynucleotides
09/05/2007EP1827460A1 Nucleosides with antiviral and anticancer activity
09/05/2007CN101031573A Heteroatoms-containing tricyclic compounds
09/05/2007CN101029068A Synthesis of 2',3'-didesoxy-3'-deoxythymidine
09/05/2007CN100335649C Reduction of nonspecific hybridization by using novel base-pairing schemes
09/05/2007CN100335492C Process for the production of 3'-nucleoside prodrugs
09/04/2007US7265111 inhibitors of lipolysis, as cardioprotective agents or they may be of value in the therapy of diabetes
09/04/2007US7265096 treat or prevent diseases or disorders such as cancer or viral infections
09/04/2007US7264931 Method for sequencing nucleic acid sequences without chain termination
09/04/2007US7264927 Isolation and purification of nucleic acids
09/04/2007CA2205350C Process for purifying and isolating 2'-deoxy-2',2'-difluoronucleosides
08/2007
08/30/2007WO2007097643A1 Analogues of coformycin and their use for treating protozoan parasite infections
08/30/2007WO2007097447A1 Method for removal of nucleic acid-protecting group
08/30/2007WO2005023203A3 Transition state analog inhibitors of ricin a-chain
08/30/2007WO2000001393A8 OLIGONUCLEOTIDE INHIBITORS OF bcl-xL
08/30/2007US20070203334 Process for preparing a synthetic intermediate for preparation of branched nucleosides
08/30/2007US20070203090 N-pyrazole A2A receptor agonists
08/30/2007US20070203075 Novel lactam ring-opening enzyme and use thereof
08/30/2007US20070202576 Labeled-imidazole-Polyethylene glycol compounds; nonpurine- and nonpyrimidine-based nucleotides; nucleotide sequence detectors; polymerization in the presence of deoxynucleotidyl transferase
08/30/2007CA2642693A1 Method for removal of nucleic acid-protecting group
08/29/2007EP1824805A1 Method for preparation of organofluoro compounds in alcohol solvents
08/29/2007CN101024667A Method for preparing gemcitabine hydrochloride
08/29/2007CN101024666A (1-arylseleno-3-triethyamino) glycerol tegafur thiophosphates compounds and its synthesization
08/29/2007CN100334101C Method for synthesizing 2',3'-dideoxy cytidine
08/29/2007CN100334100C Method for synthesizing 5-trifluoro methyl-2'-desugarized uridine
08/28/2007US7262176 useful in the treatment of neurological, cardiac, and other cellular proliferative disorders
08/28/2007CA2504078C Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides
08/23/2007US20070197796 Process for producing indolopyrrolocarbazole derivative
08/23/2007US20070197561 Inhibitors of nucleoside metabolism
08/23/2007US20070197463 Antiviral nucleosides
08/23/2007US20070197462 Administering 5-substituted uracil-nucleosides or its pharmaceutically acceptable salt or prodrug for therapy of infected with Epstein-Barr virus (EBV) or Kaposi's sarcoma-associated herpes (KHSV)
08/23/2007US20070197454 P1-(2'-deoxycytidine 5'-)p4-(uridine 5'-)tetraphosphate, tetra-(alkali metal) salt, for treating disorders
08/23/2007US20070196852 Labeling reagent
08/23/2007US20070196824 1st and 2nd primer sets provide a first detectable signal on the occurrence of amplification of mitochondrial nucleic acid and second signal on the occurrence of amplification of host nuclear nucleic acid; probe comprising a 6-carboxyfluorescein reporter, 5-carboxytetramethylrhodamine quencher molecule
08/23/2007CA2637879A1 Nucleoside aryl phosphoramidates for the treatment of rna-dependent rna viral infection
08/22/2007EP1819718A1 Difluoronucleosides and process for preparation thereof
08/22/2007EP1402024B1 Templated molecules and methods for using such molecules
08/22/2007CN101023094A Preparation of alkyl-substituted 2-deoxy-2-fluoro-d-ribofuranosyl pyrimidines and purines and their derivatives
08/22/2007CN101020708A Process of preparing dibutyryl adenosine cyclophosphate
08/22/2007CN101020707A Process of refining calcium dibutyryl adenosine cyclophosphate
08/21/2007USRE39793 Compositions for sorting polynucleotides
08/21/2007US7259258 Methods of attaching biological compounds to solid supports using triazine
08/21/2007CA2150940C Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis
08/16/2007WO2007092372A1 Process for preparing an a2a-adenosine receptor agonist and its polymorphs
08/16/2007WO2007092213A2 Inhibitors of e1 activating enzyme
08/16/2007US20070191598 Process for Preparing Gemcitabine and Associated Intermediates
08/16/2007US20070191339 Crystalline forms of a pharmaceutical compound
08/16/2007US20070191301 for reducing animal core temperatures and rate of oxygen consumption; protecting against myocardial damage during cardioplegia; cardiovascular disease, neurological disorders, ophthalmic conditions, ischemic conditions, reperfusion injury, obesity, wasting disease, and/or diabetes
08/16/2007US20070191293 Inhibitors of E1 activating enzymes
08/16/2007US20070190564 Universal nucleotides for nucleic acid analysis
08/16/2007US20070190546 Sequencing nucleic acid molecules; promote accurate base-over-base incorporation in sequencing-by-synthesis reactions, resulting in greater read lengths
08/16/2007US20070190530 Conversion of a cytosine to a uracil base in a nucleic acid; incubating solution containing nucleic acid and guanidinium and sulfite ions whereby the nucleic acid is deaminated, incubating deaminated nucleic acid under alkaline conditions to desulfonate; detecting methylated cytosine
08/16/2007CA2787759A1 Process for preparing an a2a-adenosine receptor agonist and its polymorphs
08/16/2007CA2640089A1 Process for preparing an a2a-adenosine receptor agonist and its polymorphs
08/16/2007CA2639924A1 Inhibitors of e1 activating enzymes
08/15/2007EP1817317A1 Methods for preparing pimecrolimus
08/15/2007EP1817316A1 Ascomycin crystalline forms and preparation thereof
08/15/2007EP1817315A1 Processes for producing crystalline macrolides
08/15/2007EP1817314A1 Non-hygroscopic and powdery amorphous pimecrolimus
08/15/2007EP1638984B1 Avermectin b1 monosaccharide derivatives
08/15/2007CN101018859A Mucin 3 EFG-like domains
08/15/2007CN101018799A Composition and method for inhibiting platelet aggregation
08/15/2007CN101016323A Method of reclaiming adenosine from low concentration Chinese caterpillar fungus fermentation waste water by large aperture adsorption resin
08/15/2007CN101016322A Preparing method of Azidothimidine cholesterol carbonate, preparation and analytical method thereof
08/15/2007CN101016319A Benzoisoselenothiazolidone aminosugar derivative, preparing method and application therheof
08/14/2007US7256291 cyanine dyes, xanthene dyes, porphyrin dyes, coumarin dyes or composite dyes; genetic probes for real-time detection; solid phase synthesis
08/14/2007US7256179 Oligonucleotides for treating drug resistant HBV infections that may contain contain one or more alkylphosphonate, phosphorothioate, phosphorodithioate, alkylphosphonothioate, phosphoroamidate, carbamate, carbonate, phosphate trimester, acetamidate, carboxymethyl ester linkage nucleotide linkages
08/14/2007US7255995 Analyte assay using particulate labels
08/09/2007WO2007041637A3 Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias
08/09/2007US20070185062 Phosponate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production
08/09/2007US20070185041 bis-(3-deoxy-3-(4-(methylaminocarbonyl)-1H-[1,2,3]-triazol-1-yl)-beta-D-galactopyranosyl)sulfane; pharmacokinetics
08/09/2007US20070184471 Analyte assay using particulate labels
08/09/2007US20070183995 Compounds useful as agonists of A2A adenosine receptors, cosmetic compositions with A2A agonists and a method for using the same
08/09/2007DE20122767U1 Massives Parallelverfahren zur Dekodierung von DNA und RNA Massive parallel method for decoding DNA and RNA
08/09/2007CA2640171A1 6-modified bicyclic nucleic acid analogs
08/08/2007EP1816135A1 Production method of fluorinated purine nucleoside derivative, intermediate therefor and production method thereof
08/08/2007EP1815022A2 Method of determining a cellular response to a biological agent
08/08/2007EP1814895A2 Apparatus and system having dry control gene silencing compositions
08/08/2007EP1501848B1 Synthesis of locked nucleic acid derivatives
08/08/2007EP1397377A4 Calix 4|arene-nucleoside and calix 4|arene-oligonucleotide hybrids
08/08/2007EP0927180B1 Heterocyclic compounds and their use for isolating nucleic acids
08/08/2007CN1330660C Process for the preparation of 2'-halo-beta-l-arabinofuranosyl nucleosides
08/08/2007CN101012261A Method of producing adenosine disodium triphosphate
08/08/2007CN101012260A Technique for producing 2,6-dichlorine purine nucleosides by chemical synthesis method
08/08/2007CN101012259A 3'-prodrugs of 2'-deoxy-beta-l-nucleosides
08/08/2007CN101012247A Method for preparing nucleotide from enzymolysis liquid of ribonuclease
08/07/2007US7253277 Nanoparticle polyanion conjugates and methods of use thereof in detecting analytes
08/07/2007US7253254 Polypeptide variants with increased heparin-binding capacity
08/02/2007WO2007044937A3 Compositions and methods to modulate memory
08/02/2007WO2005012545A3 Cytomegalovirus gene function and methods for developing antivirals, anti-cmv vaccines, and cmv-based vectors
08/02/2007US20070179290 Production method of fluorinated purine nucleoside derivative, intermediate therefor and production method thereof
1 ... 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 ... 201